Skip to main content

Table 4 Annualized adjusted total excess cost of community acquired pneumonia by selected comorbidity group

From: Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults

Type of excess cost   All Patients No key comorbidity Comorbid group
     Asthma Diabetes COPD CHF
Total medical Mean $11,395 $9,866 $10,158 $16,351 $17,039 $31,593
  (SE) ($42) ($43) ($109) ($165) ($186) ($531)
  (95% CI) ($11,312, $11,477) ($9,782, $9,951) ($9,945, $10,371) ($16,027, $16,674) ($16,674, $17,404) ($30,553, $32,634)
Total productivity costs Mean $3,034 $2,734 $3,149 $5,044 $6,454 $2,842
  (SE) ($55) ($45) ($272) ($263) ($329) ($752)
  (95% CI) ($2,927, $3,141) ($2,645, $2,823) ($2,616, $3,681) ($4,528, $5,561) ($5,810, $7,098) ($1,369, $4,316)
Total cost Mean $14,429 $12,601 $13,307 $21,395 $23,493 $34,436
  (SE) ($44) ($44) ($123) ($171) ($197) ($549)
  (95% CI) ($14,343, $14,514) ($12,514, $12,687) ($13,066, $13,548) ($21,061, $21,730) ($23,106, $23,880) ($33,360, $35,511)
Total cost relative to patients without selected comorbidities   1.15 1.00 1.06 1.70 1.86 2.73
  1. Abbreviation: COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; SE, standard error; CI: confidence interval.
  2. Note: comorbid groups are not mutually exclusive. Cost estimates are from generalized linear regressions.
  3. All excess cost estimates are significant at p<0.01.